Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.
Kourelis TV, Buadi FK, Gertz MA, Lacy MQ, Kumar SK, Kapoor P, Go RS, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, Hwa YL, Gonsalves W, Kyle RA, Dispenzieri A.
Kourelis TV, et al. Among authors: go rs.
Leukemia. 2016 May;30(5):1079-85. doi: 10.1038/leu.2015.344. Epub 2015 Dec 16.
Leukemia. 2016.
PMID: 26669974